ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. ( China (Mainland))

ZHEJIANG HISUN PHARMACEUTICAL CO., LTD., founded in 1956, is located in southeast China coastal port city --- Taizhou, Zhejiang Province. In 2000, HISUN is being listed on the Shanghai Stock Exchange. HISUN has about 3,000 employees, of which more than one-third are scientists and engineers. In 2001 HISUN established a national recognized enterprise technology center and post-doctoral research station.Technology Center has more than 50 units laboratories which is engaged in chemical synthesis, microbial fermentation, biotechnology, natural plant extraction and preparation, and so on. The products involved in anti-tumor therapeutic areas, cardiovascular system, anti-infective, anti-parasitic insects, endocrine regulation, immune suppression, anti-depressants and so on. Some of them are Tacrlimus (104987-11-3) capsules, Amoxycillin (61336-70-7) capsules, Bicalutamide (90357-06-5) tablets, Isosorbide mononitrate (16051-77-7) tablets, Loxapine succinate (27833-64-3) capusles, and so on. HISUN carried on ISO14001 Environmental Management System, OHSAS18001 occupational health and safety management system and the SA8000 social responsibility management system. In 1992, HISUN is gaining the first FDA certification. At present, 18 products have been approved to enter the U.S. market and 14 products have passed CEP certification.